Exact Mass: 396.2736

Exact Mass Matches: 396.2736

Found 50 metabolites which its exact mass value is equals to given mass value 396.2736, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

Estradiol Cypionate

Estra-1,3,5(10)-triene-3,17-diol (17.beta.)-, 17-cyclopentanepropanoate

C26H36O3 (396.2664)


C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C1636 - Therapeutic Steroid Hormone C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C483 - Therapeutic Estrogen D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials D012102 - Reproductive Control Agents > D003270 - Contraceptive Agents Same as: D04063 Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS

   

1-hexadecyl-glycero-3-phosphate

[(2R)-3-(hexadecyloxy)-2-hydroxypropoxy]phosphonic acid

C19H41O6P (396.2641)


1-hexadecyl-glycero-3-phosphate is also known as PA(O-16:0/0:0). 1-hexadecyl-glycero-3-phosphate is considered to be practically insoluble (in water) and acidic. 1-hexadecyl-glycero-3-phosphate is a glycerophosphate lipid molecule

   

(2E,4E,6E,8E)-3,7-Dimethyl-9-(2-nonoxyphenyl)nona-2,4,6,8-tetraenoic acid

(2E,4E,6E,8E)-3,7-Dimethyl-9-(2-nonoxyphenyl)nona-2,4,6,8-tetraenoic acid

C26H36O3 (396.2664)


   

estradiol cypionate

5-hydroxy-15-methyltetracyclo[8.7.0.0²,⁷.0¹¹,¹⁵]heptadeca-2,4,6-trien-14-yl 3-cyclopentylpropanoate

C26H36O3 (396.2664)


   

[(8R,9S,13S,14S,17S)-17-Hydroxy-13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthren-3-yl] 3-cyclopentylpropanoate

[(8R,9S,13S,14S,17S)-17-Hydroxy-13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthren-3-yl] 3-cyclopentylpropanoic acid

C26H36O3 (396.2664)


   

Strongylophorin 4

Strongylophorin 4

C26H36O3 (396.2664)


   

Strongylophorin 24

Strongylophorin 24

C26H36O3 (396.2664)


   

Neurymenolide B

Neurymenolide B

C26H36O3 (396.2664)


   

24,25,26,27-tetranortirucall-1,7-diene-23(21)-lactone

24,25,26,27-tetranortirucall-1,7-diene-23(21)-lactone

C26H36O3 (396.2664)


   

Thiothece 425

Thiothece 425

C26H36O3 (396.2664)


   

plakortone P

plakortone P

C26H36O3 (396.2664)


An organic heterobicyclic compound consisting of a gamma-lactone ring fused onto a substituted tetrahydrofuran ring. It is isolated from the Australian marine sponge Plakinastrella clathrata.

   

1-Hexadecyl Lysophosphatidic Acid

3-(hexadecyloxy)-1-(dihydrogen phosphate)-1,2-propanediol

C19H41O6P (396.2641)


   

PA(O-16:0/0:0)

1-hexadecyl-glycero-3-phosphate

C19H41O6P (396.2641)


   

LPA O-16:0

1-hexadecyl-glycero-3-phosphate

C19H41O6P (396.2641)


   

4-PENTYLPHENYL 4-OCTYLOXYBENZOATE

4-PENTYLPHENYL 4-OCTYLOXYBENZOATE

C26H36O3 (396.2664)


   

ISONONAMIDOPROPYL ETHYLDIMONIUM ETHOSULFATE

ISONONAMIDOPROPYL ETHYLDIMONIUM ETHOSULFATE

C18H40N2O5S (396.2658)


   

butan-2-one O-[[[[1,3,3-trimethyl-5-[[[[(1-methylpropylidene)amino]oxy]carbonyl]amino]cyclohexyl]methyl]amino]carbonyl]oxime

butan-2-one O-[[[[1,3,3-trimethyl-5-[[[[(1-methylpropylidene)amino]oxy]carbonyl]amino]cyclohexyl]methyl]amino]carbonyl]oxime

C20H36N4O4 (396.2736)


   

N3-Asp(tBu)-OH (dicyclohexylammonium) salt

N3-Asp(tBu)-OH (dicyclohexylammonium) salt

C20H36N4O4 (396.2736)


   

(4-octoxyphenyl) 4-pentylbenzoate

(4-octoxyphenyl) 4-pentylbenzoate

C26H36O3 (396.2664)


   

4-(5-octyl-2-pyrimidinyl)phenyl heptanoate

4-(5-octyl-2-pyrimidinyl)phenyl heptanoate

C25H36N2O2 (396.2777)


   

(2E,4E,6E,8E)-3,7-Dimethyl-9-(2-nonoxyphenyl)nona-2,4,6,8-tetraenoic acid

(2E,4E,6E,8E)-3,7-Dimethyl-9-(2-nonoxyphenyl)nona-2,4,6,8-tetraenoic acid

C26H36O3 (396.2664)


D020011 - Protective Agents > D000975 - Antioxidants > D002338 - Carotenoids

   

[3-Carboxy-2-[5-(3-methyl-5-pentylfuran-2-yl)pentanoyloxy]propyl]-trimethylazanium

[3-Carboxy-2-[5-(3-methyl-5-pentylfuran-2-yl)pentanoyloxy]propyl]-trimethylazanium

C22H38NO5+ (396.275)


   

[3-Carboxy-2-[7-(3-methyl-5-propylfuran-2-yl)heptanoyloxy]propyl]-trimethylazanium

[3-Carboxy-2-[7-(3-methyl-5-propylfuran-2-yl)heptanoyloxy]propyl]-trimethylazanium

C22H38NO5+ (396.275)


   

3-cyclopentylpropanoic acid [(13S,17S)-3-hydroxy-13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthren-17-yl] ester

3-cyclopentylpropanoic acid [(13S,17S)-3-hydroxy-13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthren-17-yl] ester

C26H36O3 (396.2664)


   

N-[[(2S,3R,4S)-3-[4-(1-cyclohexenyl)phenyl]-1-(cyclopropylmethyl)-4-(hydroxymethyl)-2-azetidinyl]methyl]-N-ethylacetamide

N-[[(2S,3R,4S)-3-[4-(1-cyclohexenyl)phenyl]-1-(cyclopropylmethyl)-4-(hydroxymethyl)-2-azetidinyl]methyl]-N-ethylacetamide

C25H36N2O2 (396.2777)


   

1-[(2S,3R,4S)-2-[(cyclobutylmethylamino)methyl]-3-[4-(1-cyclohexenyl)phenyl]-4-(hydroxymethyl)-1-azetidinyl]-1-propanone

1-[(2S,3R,4S)-2-[(cyclobutylmethylamino)methyl]-3-[4-(1-cyclohexenyl)phenyl]-4-(hydroxymethyl)-1-azetidinyl]-1-propanone

C25H36N2O2 (396.2777)


   

cyclobutyl-[(2S,3R,4R)-3-[4-(1-cyclohexenyl)phenyl]-2-(hydroxymethyl)-4-(propylaminomethyl)-1-azetidinyl]methanone

cyclobutyl-[(2S,3R,4R)-3-[4-(1-cyclohexenyl)phenyl]-2-(hydroxymethyl)-4-(propylaminomethyl)-1-azetidinyl]methanone

C25H36N2O2 (396.2777)


   

1-[(2S,3R,4S)-3-[4-(1-cyclohexenyl)phenyl]-2-(hydroxymethyl)-4-[(propan-2-ylamino)methyl]-1-azetidinyl]-2-cyclopropylethanone

1-[(2S,3R,4S)-3-[4-(1-cyclohexenyl)phenyl]-2-(hydroxymethyl)-4-[(propan-2-ylamino)methyl]-1-azetidinyl]-2-cyclopropylethanone

C25H36N2O2 (396.2777)


   

N-[[(2R,3S,4R)-3-[4-(1-cyclohexenyl)phenyl]-1-(cyclopropylmethyl)-4-(hydroxymethyl)-2-azetidinyl]methyl]-N-ethylacetamide

N-[[(2R,3S,4R)-3-[4-(1-cyclohexenyl)phenyl]-1-(cyclopropylmethyl)-4-(hydroxymethyl)-2-azetidinyl]methyl]-N-ethylacetamide

C25H36N2O2 (396.2777)


   

N-[[(2S,3R,4S)-3-[4-(1-cyclopentenyl)phenyl]-1-(cyclopropylmethyl)-4-(hydroxymethyl)-2-azetidinyl]methyl]-N-propan-2-ylacetamide

N-[[(2S,3R,4S)-3-[4-(1-cyclopentenyl)phenyl]-1-(cyclopropylmethyl)-4-(hydroxymethyl)-2-azetidinyl]methyl]-N-propan-2-ylacetamide

C25H36N2O2 (396.2777)


   

1-hexadecyl-sn-glycerol 3-phosphate

1-hexadecyl-sn-glycerol 3-phosphate

C19H41O6P (396.2641)


A 1-alkyl-sn-glycerol 3-phosphate in which the 1-alkyl group is specified as hexadecyl.

   
   

LG100754

LG100754

C26H36O3 (396.2664)


LG100754 (UVI 2112) is a RXR dimers modulater. LG100754 acts as a RXR:RXR homodimer antagonist, but functions as a agonist towards RXR:PPARα and RXR:PPARγ heterodimers. LG100754 is an insulin sensitizer that functions through RXR[1].

   

4-{3a,6,6,9a,11a-pentamethyl-7-oxo-1h,2h,3h,5h,5ah,9bh,10h,11h-cyclopenta[a]phenanthren-1-yl}oxolan-2-one

4-{3a,6,6,9a,11a-pentamethyl-7-oxo-1h,2h,3h,5h,5ah,9bh,10h,11h-cyclopenta[a]phenanthren-1-yl}oxolan-2-one

C26H36O3 (396.2664)


   

(2e,4e,6e)-7-[(1s,2s,4ar,8ar)-2-[(2r,3r)-3-[(2r)-butan-2-yl]-2-methyloxiran-2-yl]-3,6-dimethyl-1,2,4a,5,8,8a-hexahydronaphthalen-1-yl]hepta-2,4,6-trienoic acid

(2e,4e,6e)-7-[(1s,2s,4ar,8ar)-2-[(2r,3r)-3-[(2r)-butan-2-yl]-2-methyloxiran-2-yl]-3,6-dimethyl-1,2,4a,5,8,8a-hexahydronaphthalen-1-yl]hepta-2,4,6-trienoic acid

C26H36O3 (396.2664)


   

9-[2-(but-2-en-2-yl)-5-hydroxy-1,3,6-trimethyl-4a,5,6,7,8,8a-hexahydro-2h-naphthalen-1-yl]nona-2,4,6,8-tetraenoic acid

9-[2-(but-2-en-2-yl)-5-hydroxy-1,3,6-trimethyl-4a,5,6,7,8,8a-hexahydro-2h-naphthalen-1-yl]nona-2,4,6,8-tetraenoic acid

C26H36O3 (396.2664)


   

10-hydroxy-1,4a,6a,12b-tetramethyl-2h,3h,4h,4bh,5h,6h,12h,12ah,13h,14h,14ah-naphtho[2,1-a]xanthene-1-carbaldehyde

10-hydroxy-1,4a,6a,12b-tetramethyl-2h,3h,4h,4bh,5h,6h,12h,12ah,13h,14h,14ah-naphtho[2,1-a]xanthene-1-carbaldehyde

C26H36O3 (396.2664)


   

5,6a-dimethyl-5-(12-phenyldodeca-9,11-dien-1-yl)-dihydro-3h-furo[3,2-b]furan-2-one

5,6a-dimethyl-5-(12-phenyldodeca-9,11-dien-1-yl)-dihydro-3h-furo[3,2-b]furan-2-one

C26H36O3 (396.2664)


   

(1s,4ar,4br,6as,12as,12br,14ar)-10-hydroxy-1,4a,6a,12b-tetramethyl-2h,3h,4h,4bh,5h,6h,12h,12ah,13h,14h,14ah-naphtho[2,1-a]xanthene-1-carbaldehyde

(1s,4ar,4br,6as,12as,12br,14ar)-10-hydroxy-1,4a,6a,12b-tetramethyl-2h,3h,4h,4bh,5h,6h,12h,12ah,13h,14h,14ah-naphtho[2,1-a]xanthene-1-carbaldehyde

C26H36O3 (396.2664)


   

(1s,4ar,4bs,6as,12as,12br,14as)-10-hydroxy-1,4a,6a,12b-tetramethyl-2h,3h,4h,4bh,5h,6h,12h,12ah,13h,14h,14ah-naphtho[2,1-a]xanthene-1-carbaldehyde

(1s,4ar,4bs,6as,12as,12br,14as)-10-hydroxy-1,4a,6a,12b-tetramethyl-2h,3h,4h,4bh,5h,6h,12h,12ah,13h,14h,14ah-naphtho[2,1-a]xanthene-1-carbaldehyde

C26H36O3 (396.2664)


   

[(1e,4bs,6as,9r,10ar,10bs,12as)-2,4b,6a,9,10b,12a-hexamethyl-8-oxo-5,6,7,9,10,10a,11,12-octahydrochrysen-1-ylidene]acetic acid

[(1e,4bs,6as,9r,10ar,10bs,12as)-2,4b,6a,9,10b,12a-hexamethyl-8-oxo-5,6,7,9,10,10a,11,12-octahydrochrysen-1-ylidene]acetic acid

C26H36O3 (396.2664)


   

(2,4b,6a,9,10b,12a-hexamethyl-8-oxo-5,6,7,9,10,10a,11,12-octahydrochrysen-1-ylidene)acetic acid

(2,4b,6a,9,10b,12a-hexamethyl-8-oxo-5,6,7,9,10,10a,11,12-octahydrochrysen-1-ylidene)acetic acid

C26H36O3 (396.2664)


   

[(1z,4bs,6as,9r,10ar,10bs,12as)-2,4b,6a,9,10b,12a-hexamethyl-8-oxo-5,6,7,9,10,10a,11,12-octahydrochrysen-1-ylidene]acetic acid

[(1z,4bs,6as,9r,10ar,10bs,12as)-2,4b,6a,9,10b,12a-hexamethyl-8-oxo-5,6,7,9,10,10a,11,12-octahydrochrysen-1-ylidene]acetic acid

C26H36O3 (396.2664)


   

(4ar,4bs,6as,12as,12br,14as)-10-hydroxy-1,1,6a,12b-tetramethyl-2h,3h,4h,4bh,5h,6h,12h,12ah,13h,14h,14ah-naphtho[2,1-a]xanthene-4a-carbaldehyde

(4ar,4bs,6as,12as,12br,14as)-10-hydroxy-1,1,6a,12b-tetramethyl-2h,3h,4h,4bh,5h,6h,12h,12ah,13h,14h,14ah-naphtho[2,1-a]xanthene-4a-carbaldehyde

C26H36O3 (396.2664)


   

2-methyl-2-[(3e,7e)-4,8,12-trimethyltrideca-3,7,11-trien-1-yl]chromene-5,6-diol

2-methyl-2-[(3e,7e)-4,8,12-trimethyltrideca-3,7,11-trien-1-yl]chromene-5,6-diol

C26H36O3 (396.2664)


   

(2e,4e,6e,8e)-9-[(1s,2r,4as,5s,6s,8ar)-2-[(2e)-but-2-en-2-yl]-5-hydroxy-1,3,6-trimethyl-4a,5,6,7,8,8a-hexahydro-2h-naphthalen-1-yl]nona-2,4,6,8-tetraenoic acid

(2e,4e,6e,8e)-9-[(1s,2r,4as,5s,6s,8ar)-2-[(2e)-but-2-en-2-yl]-5-hydroxy-1,3,6-trimethyl-4a,5,6,7,8,8a-hexahydro-2h-naphthalen-1-yl]nona-2,4,6,8-tetraenoic acid

C26H36O3 (396.2664)


   

7-{3,6-dimethyl-2-[2-methyl-3-(sec-butyl)oxiran-2-yl]-1,2,4a,5,8,8a-hexahydronaphthalen-1-yl}hepta-2,4,6-trienoic acid

7-{3,6-dimethyl-2-[2-methyl-3-(sec-butyl)oxiran-2-yl]-1,2,4a,5,8,8a-hexahydronaphthalen-1-yl}hepta-2,4,6-trienoic acid

C26H36O3 (396.2664)


   

(4s)-4-[(1s,3as,5ar,9ar,9br,11as)-3a,6,6,9a,11a-pentamethyl-7-oxo-1h,2h,3h,5h,5ah,9bh,10h,11h-cyclopenta[a]phenanthren-1-yl]oxolan-2-one

(4s)-4-[(1s,3as,5ar,9ar,9br,11as)-3a,6,6,9a,11a-pentamethyl-7-oxo-1h,2h,3h,5h,5ah,9bh,10h,11h-cyclopenta[a]phenanthren-1-yl]oxolan-2-one

C26H36O3 (396.2664)


   

2-methyl-2-[(7e)-4,8,12-trimethyltrideca-3,7,11-trien-1-yl]chromene-5,6-diol

2-methyl-2-[(7e)-4,8,12-trimethyltrideca-3,7,11-trien-1-yl]chromene-5,6-diol

C26H36O3 (396.2664)